Search results for "cancer diagnosis"

In Vivo Fluorescence Imaging of Angiogenic Vessels in Liver Cancer Animal Model Using the iBox Explorer Imaging Microscope

Researchers present data at breast cancer symposium showing MammaPrint/BluePrint can identify women who benefit from chemotherapy and targeted dual anti-HER2 drug treatment before surgery

Stop by booth 1911/1915

The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity

MOBILion joins with investigators at the University of Georgia’s Complex Carbohydrate Research Center

Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

Dr. Clifton Ray discusses the potential of Nanotrap particles to advance extracellular vesicle research, and how his team is using them to break down barriers in isolation, screening, and disease diagnostics

The BluePrint Molecular Subtyping Profile combined with the patient's MammaPrint test result, provides a greater level of clinical information to assist in therapeutic decision-making. BluePrint is an 80-gene expression signature which classifies breast cancer into Basal-type, Luminal-type and ERBB2-type cancers. An increasing body of evidence in the medical community suggests that breast cancer patients within these molecular…

To meet all your business challenges, Oracle for Life Sciences delivers a powerful combination of technology and comprehensive, preintegrated business applications, including key functionality built specifically for pharmaceutical, biotech and medical device enterprises. Oracle offers a unified data model that gathers and synchronizes real-time information across your organization, including multiple research programs, regulat…